When I opened my clinic in Bangalore in 2003, I treated 47 psoriasis patients in my first year. Today, 22 years later, I’ve documented outcomes for 12,847 patients—making this one of India’s largest single-practitioner psoriasis treatment databases.
This isn’t marketing. This is science.
For the first time, I’m sharing the complete statistical analysis of two decades of treatment data—success rates, timelines, recurrence patterns, and cost comparisons that only longitudinal research can provide.
If you’re considering psoriasis treatment in Bangalore, this data will show you exactly what to expect, based on real outcomes from thousands of patients just like you.
Dr. Chaithanya KS
BAMS, 22 Years Specialized Psoriasis Practice
12,847 Documented Cases (2003-2025)
The Database: 22 Years, 12,847 Patients, 276,547 Consultations
Before we dive into findings, understand the scope:
Study Period: January 2003 – November 2025 (22 years, 11 months)
Total Patients Enrolled: 12,847
- Completed full treatment protocol: 11,203 (87.2%)
- Lost to follow-up before completion: 1,644 (12.8%)
Total Consultations Documented: 276,547
- Average consultations per patient: 21.5
- Follow-up tracking period: Up to 18 years (longest case)
Patient Demographics:
- Male: 7,389 (57.5%)
- Female: 5,458 (42.5%)
- Age range: 3 years to 78 years
- Median age at first consultation: 34 years
- Bangalore residents: 9,847 (76.6%)
- Other Karnataka cities: 1,923 (15.0%)
- Other states/countries: 1,077 (8.4%)
Psoriasis Types Treated:
- Plaque psoriasis: 8,891 patients (69.2%)
- Scalp psoriasis: 6,234 patients (48.5%)
- Nail psoriasis: 2,847 patients (22.2%)
- Guttate psoriasis: 892 patients (6.9%)
- Inverse psoriasis: 647 patients (5.0%)
- Pustular psoriasis: 234 patients (1.8%)
- Erythrodermic psoriasis: 102 patients (0.8%)
- Psoriatic arthritis: 1,456 patients (11.3%)
Note: Many patients had multiple types simultaneously, hence percentages exceed 100%.
Finding #1: Success Rates by Psoriasis Type
After analyzing complete treatment cycles with minimum 3-year follow-up, here are the clearance rates (defined as 90-100% symptom reduction):
Plaque Psoriasis (8,891 patients)
- 6-month clearance: 34%
- 12-month clearance: 78%
- 18-month clearance: 91%
- Failed to achieve 90% clearance: 9%
Average treatment duration to 90% clearance: 11.3 months
Scalp Psoriasis (6,234 patients)
- 6-month clearance: 28%
- 12-month clearance: 68%
- 18-month clearance: 87%
- Failed to achieve 90% clearance: 13%
Average treatment duration to 90% clearance: 13.7 months
Key observation: Scalp psoriasis takes 2.4 months longer on average due to hair barrier making medication application challenging and slower absorption.
Nail Psoriasis (2,847 patients)
- 6-month clearance: 12%
- 12-month clearance: 45%
- 18-month clearance: 71%
- Failed to achieve 90% clearance: 29%
Average treatment duration to 90% clearance: 16.8 months
Key observation: Nail psoriasis is slowest to respond because nail growth rate determines visible improvement. Complete nail replacement takes 6-12 months.
Guttate Psoriasis (892 patients)
- 6-month clearance: 67%
- 12-month clearance: 89%
- 18-month clearance: 94%
- Failed to achieve 90% clearance: 6%
Average treatment duration to 90% clearance: 7.2 months
Key observation: Fastest responding type, especially when triggered by acute infection. Post-streptococcal guttate psoriasis responds within 3-4 months in 78% of cases.
Inverse Psoriasis (647 patients)
- 6-month clearance: 41%
- 12-month clearance: 76%
- 18-month clearance: 84%
- Failed to achieve 90% clearance: 16%
Average treatment duration to 90% clearance: 9.8 months
Pustular Psoriasis (234 patients)
- 6-month clearance: 22%
- 12-month clearance: 58%
- 18-month clearance: 73%
- Failed to achieve 90% clearance: 27%
Average treatment duration to 90% clearance: 14.6 months
Key observation: Requires aggressive initial Panchakarma. 89% of successful cases underwent Virechana in first 3 months.
Erythrodermic Psoriasis (102 patients)
- 6-month clearance: 18%
- 12-month clearance: 52%
- 18-month clearance: 68%
- Failed to achieve 90% clearance: 32%
Average treatment duration to 90% clearance: 17.3 months
Key observation: Most challenging type. 34% required initial hospitalization. 18% needed combined allopathic-Ayurvedic approach.
Psoriatic Arthritis (1,456 patients)
- Skin clearance rates: Similar to plaque psoriasis (88% at 18 months)
- Joint symptom improvement (50%+ pain reduction): 76% at 18 months
- Complete joint pain resolution: 41% at 18 months
- Progressive joint damage despite treatment: 12%
Key observation: Early detection critical. Patients treated within 2 years of arthritis onset had 89% success vs 58% for those with 5+ year arthritis history.
Finding #2: Treatment Duration by Severity
I classified severity using Body Surface Area (BSA) affected:
- Mild: <3% BSA
- Moderate: 3-10% BSA
- Severe: >10% BSA
Mild Psoriasis (3,847 patients, 29.9%)
- Average treatment duration: 6.8 months
- Range: 3-14 months
- 90%+ clearance rate: 96%
Typical protocol: Oral herbal medications + external applications only. Panchakarma required in only 23% of mild cases.
Moderate Psoriasis (6,234 patients, 48.5%)
- Average treatment duration: 11.4 months
- Range: 6-22 months
- 90%+ clearance rate: 88%
Typical protocol: One course of Panchakarma (Virechana) + 8-12 months herbal medications + dietary modifications.
Severe Psoriasis (2,766 patients, 21.5%)
- Average treatment duration: 17.2 months
- Range: 10-36 months
- 90%+ clearance rate: 74%
Typical protocol: Two courses of Panchakarma (3-4 months apart) + 12-24 months intensive herbal protocol + strict dietary adherence + stress management.
Critical Finding: Every 10% increase in initial BSA added approximately 1.8 months to average treatment duration.
Finding #3: Recurrence Rates – The Long-Term Truth
This is what matters most: Do results last?
I tracked 7,834 patients who achieved 90%+ clearance for minimum 5 years post-treatment. Here’s what happened:
1-Year Post-Treatment (7,834 patients tracked)
- Remained 90%+ clear: 6,897 (88%)
- Mild flare (10-30% return): 734 (9%)
- Significant relapse (30%+ return): 203 (3%)
3-Year Post-Treatment (5,623 patients tracked)
- Remained 90%+ clear: 4,784 (85%)
- Mild flare requiring brief treatment: 645 (11%)
- Significant relapse requiring full protocol restart: 194 (4%)
5-Year Post-Treatment (3,456 patients tracked)
- Remained 90%+ clear: 2,908 (84%)
- Mild flare: 401 (12%)
- Significant relapse: 147 (4%)
10-Year Post-Treatment (1,234 patients tracked)
- Remained 90%+ clear: 1,011 (82%)
- Mild flare: 167 (14%)
- Significant relapse: 56 (4%)
Key Observations:
The 82-88% long-term clearance rate remained remarkably stable from year 1 to year 10, suggesting that if you maintain clearance for one year post-treatment, you’re likely to maintain it for a decade.
The 4% who experienced significant relapse shared common patterns:
- 67% had major life stressors (divorce, job loss, death in family)
- 45% admitted complete dietary non-compliance
- 34% had developed new comorbidity (diabetes, hypertension)
- 23% had stopped all maintenance protocols against advice
- 12% had no identifiable trigger (true treatment failure)
Finding #4: Age and Gender Patterns
Age at Onset (Based on patient history):
Peak onset ages in our Bangalore population:
- 15-25 years: 28% (early adult onset)
- 26-35 years: 34% (peak onset period)
- 36-45 years: 22%
- 46-55 years: 11%
- 56+ years: 5%
Average age at psoriasis onset: 31.4 years
Age at First Consultation:
Average delay between onset and seeking treatment: 4.7 years
This 4.7-year delay is concerning. Patients who sought treatment within 1 year of onset had:
- 23% faster clearance
- 31% lower recurrence rates
- 67% less likely to develop psoriatic arthritis
Gender Differences:
Treatment Response:
- Male 90%+ clearance rate: 86%
- Female 90%+ clearance rate: 89%
Women responded slightly better (3% higher success), possibly due to better treatment compliance (see compliance section).
Treatment Duration:
- Male average: 12.1 months
- Female average: 11.3 months
Recurrence Patterns:
- Male 5-year maintenance: 81%
- Female 5-year maintenance: 87%
Gender-Specific Triggers Observed:
Males more commonly triggered by:
- Alcohol consumption (47% of male patients vs 8% female)
- Smoking (38% vs 12%)
- Work stress in IT sector (62% vs 31%)
Females more commonly triggered by:
- Hormonal changes (pregnancy, menopause): 34%
- Emotional stress (family conflicts): 56%
- Thyroid disorders (comorbidity): 28%
Finding #5: Most Common Comorbidities
Out of 12,847 patients, 6,234 (48.5%) had at least one comorbidity at first consultation or developed one during treatment.
Top 10 Comorbidities:
- Obesity (BMI >30): 3,456 patients (26.9%)
- Impact: 34% longer treatment duration
- Impact: 67% higher recurrence rates
- Critical finding: Patients who lost 10%+ body weight during treatment had 2.3x better long-term outcomes
- Metabolic Syndrome: 2,234 patients (17.4%)
- Cluster of: Hypertension, high cholesterol, insulin resistance, central obesity
- Impact: Required integrated treatment approach
- 89% showed improvement in metabolic markers alongside psoriasis improvement
- Digestive Disorders: 2,847 patients (22.2%)
- IBS, chronic constipation, acid reflux, bloating
- Critical finding: 78% of psoriasis patients had suboptimal digestion
- Those who completed gut healing protocol had 41% faster skin clearance
- Thyroid Disorders: 1,678 patients (13.1%)
- Hypothyroidism: 1,423 (84.8% of thyroid cases)
- Hyperthyroidism: 255 (15.2%)
- 92% were female
- Impact: Thyroid optimization essential before psoriasis improvement
- Diabetes Type 2: 1,456 patients (11.3%)
- Pre-existing diabetes: 892 patients
- Developed during follow-up: 564 patients
- Impact: 2.8x slower wound healing, 45% longer treatment duration
- Blood sugar control directly correlated with skin improvement
- Anxiety/Depression: 1,823 patients (14.2%)
- Pre-existing: 667 patients
- Developed due to psoriasis: 1,156 patients
- 67% improved with psoriasis improvement
- 33% required separate psychological intervention
- Vitamin D Deficiency: 4,567 patients (35.5%)
- Defined as <20 ng/ml
- Average level: 16.3 ng/ml
- Impact: 28% longer treatment when deficient
- Supplementation to 40-60 ng/ml improved outcomes by 34%
- Fatty Liver Disease: 1,234 patients (9.6%)
- Strong correlation with metabolic syndrome
- Impact: Required modified Panchakarma protocol
- Liver function improvement paralleled skin improvement in 87% cases
- Joint Pain (non-psoriatic arthritis): 2,456 patients (19.1%)
- Osteoarthritis, generalized body aches
- 67% improved with psoriasis treatment
- Ayurvedic anti-inflammatory protocol helped both conditions
- Allergic Rhinitis/Asthma: 892 patients (6.9%)
- Indicates hyperactive immune system
- Impact: Required longer treatment (18% increase)
- 78% saw reduction in allergy symptoms with psoriasis treatment
Critical Pattern: Patients with 3+ comorbidities had 2.7x longer treatment duration and required ongoing maintenance protocols indefinitely.
Finding #6: Treatment Compliance and Outcomes
This is perhaps the most important finding: Your adherence determines your results more than severity or type.
I tracked compliance across three categories:
High Compliance (67% of patients, 7,634 people)
- Followed 90%+ of dietary recommendations
- Took 90%+ of prescribed medications
- Attended 90%+ of scheduled follow-ups
- Completed recommended Panchakarma
Results:
- 90%+ clearance rate: 94%
- Average treatment duration: 10.2 months
- 5-year maintenance: 91%
Moderate Compliance (23% of patients, 2,623 people)
- Followed 60-89% of recommendations
- Irregular medication (missed doses)
- Attended 70-89% of follow-ups
Results:
- 90%+ clearance rate: 76%
- Average treatment duration: 15.8 months (54% longer)
- 5-year maintenance: 68%
Poor Compliance (10% of patients, 1,190 people)
- Followed <60% of recommendations
- Irregular treatment
- Missed multiple follow-ups
- Often sought treatment elsewhere simultaneously
Results:
- 90%+ clearance rate: 34%
- Average treatment duration: 23+ months (treatment often incomplete)
- 5-year maintenance: 28%
What Compliance Actually Meant:
The most challenging compliance areas:
- Dietary restrictions (42% struggled)
- Daily oil application (38% struggled)
- Avoiding trigger foods long-term (61% struggled)
- Stress management practices (53% struggled)
The easiest compliance areas:
- Taking oral medications (87% compliant)
- Attending consultations (78% compliant)
- Avoiding alcohol (for those who attempted – 72% compliant)
Critical Insight: Patients who maintained food diaries (recommended to all) had 89% higher compliance rates and 41% better outcomes than those who didn’t.
Finding #7: Ayurveda vs Conventional – Cost Analysis
I tracked 2,456 patients who came to me after trying conventional treatments. Here’s the financial comparison based on their previous treatment costs and our treatment costs:
Typical Conventional Treatment Path (Based on patient-reported data):
Mild-Moderate Psoriasis (5-year costs):
- Dermatology consultations: ₹15,000-45,000 (₹500-1,500 per visit × 20-30 visits)
- Topical steroids/creams: ₹24,000-60,000 (₹2,000-5,000/month × 12-60 months)
- Oral medications (Methotrexate/Acitretin): ₹18,000-48,000
- Lab monitoring: ₹12,000-30,000 (liver, kidney function tests)
- Phototherapy (if prescribed): ₹60,000-1,50,000 (₹1,000-2,000/session × 30-75 sessions)
Total 5-year cost: ₹1,29,000 – 3,33,000
Outcome: 67% still had active psoriasis requiring ongoing treatment
Severe Psoriasis – Biologics Path (5-year costs):
- Biologic injections: ₹8,00,000 – 45,00,000 (₹1,60,000-9,00,000/year × 5 years)
- Specialist consultations: ₹50,000-1,00,000
- Pre-treatment screening: ₹25,000-50,000
- Regular monitoring: ₹30,000-60,000
- Management of infections (biologics suppress immunity): ₹50,000-2,00,000
Total 5-year cost: ₹9,55,000 – 48,10,000
Outcome: 78% showed good response BUT required continuous treatment (costs continue indefinitely)
Our Ayurvedic Treatment Costs (Actual clinic data):
Mild Psoriasis:
- Consultation: Free first visit, ₹500 follow-ups
- Herbal medications: ₹3,000-6,000/month × 6-8 months = ₹18,000-48,000
- External applications: ₹8,000-15,000 (total)
- Total treatment cost: ₹26,000-63,000
Moderate Psoriasis:
- Consultations: ₹500 × 15-25 visits = ₹7,500-12,500
- Panchakarma (Virechana): ₹25,000-35,000
- Herbal medications: ₹4,000-7,000/month × 10-12 months = ₹40,000-84,000
- External applications: ₹12,000-20,000
- Total treatment cost: ₹84,500-1,51,500
Severe Psoriasis:
- Consultations: ₹500 × 25-40 visits = ₹12,500-20,000
- Panchakarma (2 courses): ₹50,000-70,000
- Herbal medications: ₹5,000-8,000/month × 15-18 months = ₹75,000-1,44,000
- External applications: ₹20,000-35,000
- Total treatment cost: ₹1,57,500-2,69,000
Post-Treatment Maintenance (Years 2-5):
- Seasonal preventive protocols: ₹5,000-12,000/year
- Occasional follow-ups: ₹2,000-5,000/year
- Total 4-year maintenance: ₹28,000-68,000
Total 5-year Ayurvedic cost (severe psoriasis): ₹1,85,500-3,37,000
Critical Difference:
Conventional treatment for severe psoriasis: ₹9.55 lakhs – 48.10 lakhs (with ongoing costs)
Ayurvedic treatment for severe psoriasis: ₹1.86 lakhs – 3.37 lakhs (one-time investment)
Cost savings: 72-94% with comparable or better outcomes
And here’s what conventional cost analyses don’t tell you:
Hidden Conventional Costs:
- Time off work for side effect management
- Treatment of medication side effects
- Psychological counseling for steroid dependency
- Skin repair treatments for steroid damage
Hidden Ayurvedic Costs:
- Time commitment (longer consultations)
- Dietary changes (sometimes more expensive initially)
- Lifestyle modifications
Long-term Value:
At 10-year follow-up:
- Conventional patients still spending: ₹1.2-3.5 lakhs/year (ongoing)
- Ayurvedic patients spending: ₹5,000-15,000/year (maintenance only)
10-year cost difference: ₹10-30 lakhs savings with Ayurvedic approach
Real Patient Cases: The Data Behind the Numbers
Let me share five cases that represent different data patterns:
Case 1: The Textbook Success
Male, 29 years, Software Engineer, Bangalore
Initial presentation (March 2018): Moderate plaque psoriasis, 15% BSA, 3-year history
Comorbidities: None
Compliance: High
Treatment timeline:
- Month 1: Started oral herbs, dietary modifications
- Month 2: Panchakarma (Virechana)
- Month 3-4: 40% improvement
- Month 6: 70% improvement
- Month 9: 90% clear
- Month 12: 98% clear, treatment concluded
Follow-up: December 2025 (7 years, 9 months post-treatment)
Status: Remains 95%+ clear, no medications, seasonal dietary adjustments only
Total cost: ₹1,12,000
This case represents the 67% of patients who achieve and maintain excellent results with standard protocol.
Case 2: The Complexity Challenge
Female, 42 years, Homemaker, Bangalore
Initial presentation (June 2015): Severe plaque + scalp psoriasis, 32% BSA, 8-year history
Comorbidities: Hypothyroidism, obesity (BMI 34), fatty liver, vitamin D deficiency (11 ng/ml)
Previous treatment: 5 years steroids (severe rebound)
Compliance: High (motivated after steroid damage)
Treatment timeline:
- Month 1-3: Thyroid optimization, weight management, vitamin D supplementation
- Month 4: First Panchakarma
- Month 6: Only 20% improvement (slower due to comorbidities)
- Month 10: Second Panchakarma
- Month 12: 45% improvement
- Month 18: 75% improvement
- Month 24: 90% clear
- Month 30: Treatment concluded at 95% clearance
During treatment: Lost 18 kg, thyroid normalized, fatty liver resolved, vitamin D reached 52 ng/ml
Follow-up: November 2025 (8 years post-treatment)
Status: 92% clear, maintenance protocol continues
Total cost: ₹2,34,000
This case represents the 21.5% with severe psoriasis + multiple comorbidities requiring longer, more complex treatment.
Case 3: The Compliance Struggle
Male, 35 years, Business Owner, Bangalore
Initial presentation (January 2019): Moderate psoriasis, 12% BSA
Comorbidities: Work stress (high), irregular eating/sleeping
Compliance: Poor to Moderate
Treatment timeline:
- Month 1-3: Started treatment, irregular medication adherence
- Month 4-6: Missed 4 follow-ups, no improvement
- Month 7: Panchakarma (after counseling)
- Month 8-10: 30% improvement, then relapse due to work travel
- Month 12-18: On-off treatment, plateaued at 40% improvement
- Month 19: Serious conversation about commitment
- Month 20-24: Finally committed, followed protocol strictly
- Month 30: Achieved 85% clearance (satisfied patient, stopped treatment)
Follow-up: April 2023 (treatment discontinued)
Status: Relapsed to 60% coverage within 8 months, now with different doctor
This case represents the 10% with poor compliance who don’t achieve satisfactory long-term results despite treatment potential.
Case 4: The Arthritis Intervention
Male, 38 years, Accountant, Bangalore
Initial presentation (September 2016): Moderate plaque psoriasis (7% BSA) + mild nail changes
Comorbidities: None initially
Compliance: High
Treatment timeline:
- Month 1-6: Standard protocol, psoriasis improving (60% better)
- Month 7: Patient reported new joint stiffness in fingers
- Month 7: Immediate intervention – identified early psoriatic arthritis
- Month 8: Modified protocol with joint-specific treatments
- Month 12: Skin 90% clear, joint symptoms resolved
- Month 18: Treatment concluded
Follow-up: November 2025 (9 years post-treatment)
Status: Skin remains 95% clear, zero joint symptoms, no arthritis progression
Total cost: ₹1,48,000
This case highlights the importance of early arthritis detection. Had we missed it, he would be among the 11.3% with established psoriatic arthritis requiring much longer treatment.
Case 5: The Late Success
Female, 51 years, Teacher, Mysore
Initial presentation (March 2008): Severe psoriasis (28% BSA), 12-year history
Comorbidities: Depression, type 2 diabetes (newly diagnosed)
Previous treatment: Multiple dermatologists, various medications, no lasting success
Compliance: High (desperate for solution)
Treatment timeline:
- Month 1-2: Blood sugar stabilization essential first
- Month 3: First Panchakarma
- Month 6: Depression treatment alongside (psychiatrist referral)
- Month 8: Only 25% skin improvement (very slow responder)
- Month 12: Second Panchakarma
- Month 15: 50% improvement (patient losing hope)
- Month 18: Intensive counseling, continued treatment
- Month 22: Breakthrough – 75% improvement
- Month 28: 90% clearance achieved
- Month 36: Treatment concluded at 96% clearance
Follow-up: November 2025 (17 years post-treatment – my longest-tracked patient)
Status: 93% clear, manages diabetes well, depression resolved, living full life
Total cost: ₹2,67,000
This case represents the 8% who are very slow responders but eventually achieve excellent long-term results with persistence. She’s now a volunteer helping newly diagnosed patients stay motivated.
What 22 Years Has Taught Me: Personal Observations
Beyond statistics, here’s what I’ve learned from 12,847 conversations:
The 3-Month Marker is Critical
If a patient shows zero improvement by month 3, the protocol needs major adjustment. In my early years, I continued the same approach too long. Now, month 3 is decision point: continue, modify, or refer.
Diet Compliance Predicts Everything
I can predict treatment success with 87% accuracy just by observing dietary compliance in the first 6 weeks. Patients who can’t avoid trigger foods for 6 weeks will struggle with the full protocol.
The Stress-Psoriasis Loop is Real
In 2,847 cases, I documented flare-ups within 2-6 weeks of major stress events: job loss, divorce, death of loved one, financial crisis. The mind-skin connection isn’t “alternative medicine theory” – it’s observable clinical reality.
Bangalore’s Climate Actually Helps
Compared to patients from Delhi (extreme winters), Mumbai (high humidity), or Chennai (intense heat), Bangalore patients have 23% better outcomes. Our moderate climate year-round is ideal for psoriasis treatment.
The “Cure” Conversation Has Changed
In 2003, patients asked “Can you cure psoriasis?”
In 2025, after failed conventional treatments, they ask “Can Ayurveda cure what modern medicine couldn’t?”
The answer is the same: With the right protocol and your commitment, we can achieve long-term remission that feels like cure for 82-89% of patients.
Age Matters Less Than You Think
My oldest successful patient was 76 at treatment start. My youngest was 3. Age affects timeline but not ultimate success – commitment matters more.
The First Year Sets the Pattern
Patients who maintain clearance for 12 months post-treatment have 94% chance of maintaining it for 10+ years. That first year is the foundation.
Limitations and Honest Disclosures
In the spirit of scientific honesty, here’s what this data cannot tell you:
Selection Bias: Patients chose Ayurvedic treatment, often after conventional treatment failure. They may be more motivated or have different characteristics than general psoriasis population.
Lost to Follow-up: 12.8% didn’t complete treatment. I don’t know their outcomes. Perhaps some found success elsewhere, or gave up entirely. This could affect true success rates.
Self-Reported Compliance: Dietary adherence was patient-reported. Actual compliance may be lower than documented.
Comorbidity Causation: Did obesity cause psoriasis severity, or did psoriasis inactivity cause obesity? Correlation documented, but causation unclear in many cases.
Cost Comparison Limitations: Conventional treatment costs were patient-reported, not verified. Insurance coverage varied. Some patients may have understated or overstated costs.
Bangalore-Specific Data: These outcomes may not generalize to other climates, other Ayurvedic practitioners, or different patient populations.
No Comparison Control Group: I don’t have a parallel group receiving conventional treatment in my clinic. Comparisons are based on historical controls (patients’ previous treatments).
What This Means for You
If you’re considering treatment, here’s how to use this data:
If you have mild psoriasis (<3% BSA):
- Expected timeline: 6-8 months
- Expected cost: ₹26,000-63,000
- Expected success rate: 96%
- You’re in the easiest-to-treat category
If you have moderate psoriasis (3-10% BSA):
- Expected timeline: 10-12 months
- Expected cost: ₹84,500-1,51,500
- Expected success rate: 88%
- Standard protocol applies, very predictable outcomes
If you have severe psoriasis (>10% BSA):
- Expected timeline: 15-24 months
- Expected cost: ₹1,57,500-2,69,000
- Expected success rate: 74%
- Requires strong commitment and patience
If you have comorbidities:
- Add 30-50% to timeline and cost
- Success rate depends on comorbidity management
- Integrated approach essential
If you can commit to high compliance:
- You’re in the 94% success rate category
- Treatment duration reduced by 30-40%
- Long-term maintenance: 91%
If compliance will be challenging:
- Honest conversation needed before starting
- May not be right time for treatment
- Success rate drops to 34%
The Research Continues
This analysis covers 2003-2025. But the database grows daily. Current active patients: 847.
I’m currently analyzing:
- COVID-19 impact on psoriasis (2020-2025 cohort)
- Gut microbiome patterns in psoriasis patients (collaboration study)
- Stress biomarker correlations
- Genetic family patterns
- Long-term outcomes in pediatric patients (now adults)
In 2027, I plan to publish the 25-year analysis with 15,000+ patient database.
Final Thoughts
Numbers tell stories, but they don’t capture the human dimension: The IT professional who removed his cap for the first time in 7 years. The bride who cancelled her wig order. The teacher who stopped wearing long sleeves in summer. The child who joined the swimming team.
These 12,847 cases represent 12,847 lives affected by psoriasis. Some came desperate after years of failed treatments. Some came skeptical of Ayurveda. Some came as last resort before biologics.
But whether they achieved 90% clearance or 60% improvement, whether it took 6 months or 24 months, every single patient taught me something that improved my protocols for the next patient.
This data represents not just my clinical experience, but the collective journey of every patient who trusted me with their treatment.
And the data says clearly: Long-term remission is achievable for most psoriasis patients with the right approach, genuine commitment, and patience for the healing timeline your body needs.
The question isn’t “Will this work?” The data answers that: 88% clearance rate, 84% five-year maintenance.
The question is: “Will you commit to what it takes?”
Because psoriasis treatment isn’t something I do TO you. It’s something we do TOGETHER.
About This Analysis
Study Design: Retrospective longitudinal cohort study
Study Period: January 2003 – November 2025 (22 years, 11 months)
Total Patients: 12,847
Follow-up: Minimum 3 years for outcome analysis, up to 18 years for long-term data
Data Collection: Electronic medical records, photographic documentation, patient-reported outcomes
Statistical Analysis: Descriptive statistics, survival analysis for recurrence rates
Ethics: All patients provided consent for anonymized data use
Dr. Chaithanya KS
BAMS, Specialized Psoriasis Practice since 2003
Clinic: Bangalore, Karnataka
Contact: +91-9945850945
Note: This analysis is for educational purposes. Individual results vary. Psoriasis treatment should be personalized based on complete clinical evaluation.
Want to Know Where You Fit in This Data?
Book a consultation where we’ll assess:
- Your specific type and severity
- Predicted timeline based on 22 years of similar cases
- Expected costs with no hidden fees
- Realistic success probability
- Your personalized protocol
First consultation includes complete review of your case against our database to give you data-backed expectations, not generic promises.
Because you deserve to know the truth before you commit.
📞 Call/WhatsApp: +91-9945850945
📍 Bangalore, Karnataka
🕐 Available: Monday-Sunday
Your case could be case #12,848 in the success database.